Persistent Asset Partners »

Cg Oncology shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Cg Oncology (CGON) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $513k 12k 41.52

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Molina Healthcare (MOH)
Anthem (ELV)
Intel Corporation (INTC)
Axt (AXTI)
Terns Pharmaceuticals (TERN)
Sandisk Corp (SNDK)
Abivax Sa Sponsored Ads (ABVX)
Johnson & Johnson (JNJ)
Brightspring Health Svcs (BTSG)
Viking Therapeutics Call Call Option
Viking Therapeutics (VKTX)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Nebius Group Shs Class A (NBIS)

View all positions for Persistent Asset Partners

Top funds holding Cg Oncology

Vanguard Group
Decheng Capital
Wellington Management Company
BlackRock
FMR
TCG Crossover Management
State Street Corporation
Foresite Capital Management VI
Alliancebernstein
Rtw Investments
UBS Group
Braidwell
Franklin Resources
OrbiMed Advisors
Seven Fleet Capital Management

View all funds holding Cg Oncology